Pfizer Tikosyn Roll-Out Tied To Hospital And Physician Training Program
Pfizer is developing a pilot training program in preparation for the launch of the anti-arrhythmic Tikosyn (dofetilide) in the first quarter of 2000.
Pfizer is developing a pilot training program in preparation for the launch of the anti-arrhythmic Tikosyn (dofetilide) in the first quarter of 2000.